has long been known to be involved in the control of Na balance by stimulating aldosterone secretion (7). In addition, it has been shown to have a direct renal action (3, 8, 10). M ore recently it has been shown that infusions of either renin or angiotensin result in increased levels of circulating ADH (Z), which suggests that the reninangiotensin system may be involved in the control of ADH secretion. However, no information is available as to the location of the angiotensin receptor. The work presented here was designed to obtain information relating to the location of that receptor.
METHODS

All experiments
were performed on mongrel dogs weigh ing between 10 and 22 kg, anesthetized with an intravenous injection of sodium pentobarbital (30 mg/kg). Two types of experiments were carried out. Three dogs were prepared in the following way after induction of anesthesia. One femoral artery was isolated and catheterized with polyethylene tubing. The catheter was connected with a three-way stopcock to a pressure transducer and an appropriate recording apparatus. In this way arterial blood pressure was continually monitored.
Blood samples for analysis were taken from the third outlet of the stopcock. A femoral vein was catheterized for the infusion of test solutions. One common carotid artery was isolated and a 23-gauge hypodermic needle inserted through the artery wall in the direction of flow. The other end of the needle was connected to polyethylene tubing. Venous and carotid catheters were connected to a constantinfusion pump set to deliver 0.2 ml/min into each catheter. During control periods both infusions consisted of 75 mM NaCl and 150 mM glucose. This infusion was continued for at least 1 hr following surgery, at which time an arterial blood sample was drawn for ADH estimation, Na concentration, osmolality, and hematocrit. Immediately after the first sample angiotensin (Hypertensin, Ciba) was mixed with the infusion solution of the common carotid catheter so that 10-l 7 rig/kg per min were delivered to the dog. After 30 min of infusion a second blood sample was taken and the infusion changed to saline-glucose only. Another 30 min was allowed and a third blood sample was taken. Immediately after this, the same amount of angiotensin was infused into the femoral vein catheter for 30 min and the fourth sample was obtained. Angiotensin infusion was then terminated and a final control sample was taken after 30 additional minutes. Thus, in these experiments the dog's response to angiotensin infused directly into the carotid artery was compared to the same dose infused intravenously. Seven dogs were positioned in a sterotaxic device and catheters were placed as described by Leusen (9) and Pappenheimer et al. (11) so that lateral ventriculocisternal perfusion could be initiated. Four dogs were used to study the effects of ventriculocisternal perfusion of angiotensin on ADH concentrations in plasma, and three were used for measuring the rate of disappearance of angiotensin from the perfusate. An artificial CSF, gassed with 5 % CO2 and 95 % 02 , was perfused through the ventriculocisternal system. The composition of the fluid, in millimoles per liter was as follows: Na, 151; K, 3; Ca, 1.14; Mg, 0.8; P04, 0.5; Cl, 132; HCOS , 25; and glucose, 4.15. The tip of the outflow cannula was fixed at the level of the ear bars so that CSF pressure in the ventricles was kept close to zero.
Synthetic angiotensin was added to the artificial dog CSF so as to achieve various angiotensin concentrations, ranging from 0.3 to 443 rig/ml.
All dilutions of angiotensin were carried out in siliconized vessels (Clay-Adams, Inc., Silicad), and all parts of the perfusion system coming in contact with the angiotensin-containing CSF were either plastic or siliconized glass. These precautions minimize angiotensin loss from the artificial CSF. Care was taken to flush the perfusion apparatus following angiotensin administration so as to prevent contamination of the control solution with angiotensin during the recovery period.
The perfusion rate was the same throughout a given No decrease in pressor activity was observed during this time. Samples of cisternal outflow during control (i.e., no angiotensin) CSF perfusion were also subjected to bioassay for pressor activity, and in addition, all CSF solutions containing angiotensin were assayed for pressor activity prior to their perfusion through the ventricles to check the accuracy of weighing and dilutions. In these same three animals, samples of CSF cisternal outflow were collected over short timed intervals (4-6 min) immediately after perfusion of the artificial CSF containing angiotensin, i.e., after changing from the angiotensin solution to the nonangiotensin solution. These samples were also assayed for pressor activity.
Analytical methods. route of infusion. However, the increment in the concentration of ADH in plasma was greater when angiotensin was infused into the carotid artery than in the vein. With the exception of the second control period in the third dog, all ADH concentrations returned to preinfusion values on terminating the infusion of angiotensin. We cannot explain this unusually high %ontrol" value. In any event, these data suggest that intracarotid infusion of angiotensin is a more potent stimulus to ADH release than is intravenous infusion.
In these experiments no change in the concentration of Na in plasma, osmolality, or hematocrit was observed.
Perfusion of an artificial CSF containing angiotensin in concentrations ranging from 0.3 to 443 rig/ml also resulted in a significant increase in the concentration of ADH in plasma. Figure  1 shows the results of these experiments. The changes in plasma activity of ADH were not accompanied by-changes in blood pressure, pulse pressure, heart rate, plasma osmolality, or concentration of Na. No significant change in plasma renin activity was found. In five dogs, all of which responded to angiotensin with a signifi- was considerably less than that entering the lateral ventricle. No pressor activity was detected in the control CSF or in cisternal outflow during the control perfusion, nor was there any detectable loss of pressor activity in cisternal fluid during angiotensin perfusion after remaining at room temperature for 40 to 50 min. In two dogs the pressor activity of the cisternal outflow was determined during the recovery periods following perfusion of angiotensin at three concentrations-15, 73, and 443 rig/ml. Fifteen minutes after changing to angiotensinfree CSF no activity was detected at the lowest dose. After infusing 73 rig/ml the effluent had a concentration of 4 rig/ml 15 min after changing the reinfusion and 1 rig/ml at 30 min. Following the highest dose, the outflow had concentrations of 20 and 3 rig/ml at 15 and 30 min, respectively.
From the data in Table 2 , and the known rate of perfusion (the rate of CSF outflow was within 1 % of the perfusion rate), it is possible to calculate the rate of disappearance of angiotensin from the perfusate (rate of disappear- 
